12 Result(s)

Article

Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada

Until now, there has been no standardized method of performing and presenting budget impact analyses (BIAs) in Canada. Nevertheless, most drug plan managers have been requiring this economic data to inform dru...

Dr Deborah A. Marshall, Patrick R. Douglas, Michael F. Drummond… in PharmacoEconomics (2008)

Article

Information Barriers to the Implementation of Economic Evaluations in Japan

With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and res...

Professor Shuzo Nishimura, George W. Torrance, Naoki Ikegami… in PharmacoEconomics (2002)

Article

Why Has the Use of Health Economic Evaluation in Japan Lagged Behind that in Other Developed Countries?

The aging population and the increasing availability of new medical technologies, particularly pharmaceuticals, have led to growing pressure on governments worldwide to contain healthcare costs. Increasingly, ...

Professor Naoki Ikegami, Michael Drummond, Shunichi Fukuhara… in PharmacoEconomics (2002)

Article

The Development and Use of Quality-of-Life Measures to Evaluate Health Outcomes in Japan

Health outcomes measurement forms a key aspect of data collection for economic evaluations. Quality-of-life instruments provide a measure of patient-focused health outcomes. Such instruments, including the Eur...

Professor Shunichi Fukuhara, Naoki Ikegami, George W. Torrance… in PharmacoEconomics (2002)

Article

The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals

The first edition of the Guidelines for Economic Evaluation of Pharmaceuticals: Canada was published in November 1994. At that time, the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) was ...

Dr Judith L. Glennie, George W. Torrance, Jean François Baladi… in PharmacoEconomics (1999)

Article

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

Objective: The aim of this study was to evaluate the cost effectiveness of multitherapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis.

Mr Andrew J. Rosner, Daniel T. Grima, George W. Torrance… in PharmacoEconomics (1998)

Article

Guidelines for Pharmacoeconomic Studies

This article reports the recommendations of the Panel on Cost Effectiveness in Health and Medicine, sponsored by the US Public Health Service, on standardised methods for conducting cost-effectiveness analyses...

Dr Joanna E. Siegel, George W. Torrance, Louise B. Russell… in PharmacoEconomics (1997)

Article

Multi-Attribute Health Status Classification Systems

In this article, multi-attribute approaches to the assessment of health status are reviewed with a special focus on 2 recently developed systems, the Health Utilities Index (HUI) Mark II and Mark III systems. ...

Dr David Feeny, William Furlong, Michael Boyle, George W. Torrance in PharmacoEconomics (1995)

Article

Operations Research in Hospitals: Diagnosis and Prognosis

George W. Torrance in Journal of the Operational Research Society (1974)